Evidence map›Paper›PMID 24987341›Full record

ArticleFrontiers in behavioral neuroscience2014

Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism.

Yu-Wen Chen, Hui-Ching Lin, Ming-Chong Ng, Ya-Hsin Hsiao, Chao-Chuan Wang, Po-Wu Gean, Po See Chen

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04481035 phase2completednot on this mapstarted 2019, after this paper: background citation

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

TypeinterventionalSponsorChildren's Hospital Medical Center, CincinnatiRan2019 to 2021Enrolled5ConditionsNeurofibromatosis 1ArmsN-acetylcysteine (NAC), Placebo
NCT04481048 phase2completednot on this mapstarted 2021, after this paper: background citation

Antioxidant Therapy With N-acetylcysteine for Motor Behavior and/or Learning in Children With Neurofibromatosis Type 1

TypeinterventionalSponsorChildren's Hospital Medical Center, CincinnatiRan2021 to 2024Enrolled25ConditionsNeurofibromatosis 1ArmsN-Acetyl cysteine, Placebo
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Viruses and autism: A Bi-mutual cause and effect.World journal of virology · 2023
    Review
  6. Article
  7. Sex- and age-dependent contribution of System xFrontiers in behavioral neuroscience · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Molecular neurobiology · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yu-Wen ChenDepartment of Pharmacology, College of Medicine, National Cheng-Kung University Tainan, Taiwan.
Hui-Ching LinDepartment and Institute of Physiology, School of Medicine, National Yang-Ming University Taipei, Taiwan ; Brain Research Center, National Yang-Ming University Taipei, Taiwan.
Ming-Chong NgDepartment of Psychiatry, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University Tainan, Taiwan.
Ya-Hsin HsiaoDepartment of Pharmacology, College of Medicine, National Cheng-Kung University Tainan, Taiwan.
Chao-Chuan WangDepartment of Anatomy, College of Medicine, Kaohsiung Medical University Kaohsiung, Taiwan.
Po-Wu GeanDepartment of Pharmacology, College of Medicine, National Cheng-Kung University Tainan, Taiwan.
Po See ChenDepartment of Psychiatry, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University Tainan, Taiwan ; Addiction Research Center, National Cheng Kung University Tainan, Taiwan.
National Cheng Kung University · TWNational Cheng Kung University Hospital · TWKaohsiung Medical University · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism-like phenotypes in male valproate (VPA)-exposed offspring have been linked to high glutamatergic neurotransmission in the thalamic-amygdala pathway. Glial cystine/glutamate exchange (system Xc(-)), which exchanges extracellular cystine for intracellular glutamate, plays a significant role in the maintenance of extracellular glutamate. N-acetylcysteine (NAC) is a cystine prodrug that restores extracellular glutamate by stimulating system Xc(-). In this study, we examined the effects of NAC on autism-like phenotypes and neurotransmission in the thalamic-amygdala synapses, as well as the involvement of metabotropic glutamate receptors 2/3 (mGluR2/3). Valproate-treated rats received a single intraperitoneal injection of 500 mg/kg NaVPA on E12.5. On postnatal day 21 (P21), NAC or saline was administered once daily for 10 days. From day 8 to 10, NAC was given 1/2 h prior to behavioral testing. Chronic administration of NAC restored the duration and frequency of social interaction and ameliorated anxiety-like behaviors in VPA-exposed offspring. In amygdala slices, NAC treatment normalized the increased frequency of mEPSCs and decreased the paired pulse facilitation (PPF) induced by VPA exposure. The effects of NAC on social interaction and anxiety-like behavior in the VPA-exposed offspring were blocked after intra-amygdala infusion of mGluR2/3 antagonist LY341495. The expressions of mGluR2/3 protein and mGluR2 mRNA were significantly lower in the VPA-exposed offspring. In contrast, the mGluR3 mRNA level did not differ between the saline- and VPA-exposed offspring. These results provide the first evidence that the disruption of social interaction and enhanced presynaptic excitatory transmission in VPA-exposed offspring could be rescued by NAC, which depends on the activation of mGluR2/3.

Indexed as

amygdalaautistic spectrum disordersglutamateN-acetylcysteinevalproate

Identifiers

PMID24987341
PMCPMC4060031
OpenAlexW2053154721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.